Clinical data suggests that patients who report persistent side effects beyond 8 weeks may benefit from dose adjustment or medication timing changes, which PlexusDx providers can explore without increasing your monthly cost
(2017) "Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial" The Lancet Diabetes & Endocrinology, 5(4) This article was reviewed by and approved by Alice Fletcher, Lead Bariatric Dietitian, on 3 April 2025
Below, we break down everything you need to know, including the best peptides for weight loss, oral peptide options, safety considerations and answers to the most common questions
Steps: S1: Fermentation culture of the bacteria
Your healthcare provider must complete their portion confirming medical necessity and appropriate diagnosis
